IPO Size
Price Band
Minimum Lot Size
Face Value
Employee Discount
Retail Allocation
Issue Open Date
Issue Close Date
Listing Date
As per the reports of Crisil, global Health is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.
Under the “Medanta” brand, global health has a network of four hospitals currently in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital which is under construction with an operational outpatient facility (Patna), and one hospital (Noida) planned for development. As of March 31, 2021, the firm provides healthcare services in over 30 medical specialties and engages over 1,100 doctors led by highly experienced department heads and, spanning an area of 3.7 million sq. ft., our operational hospitals have 2,176 installed beds.
S.No. | 1 - Company | 2 - Directors | 3 - Promoters | |||
Entity Name | By the Company | Against the Company | By the Director | Against the Director | By the Promoter | Against the Promoter |
Criminal cases | 1 | 3 | - | - | - | 1 |
Material civil cases | 1 | 14 | - | - | - | - |
Taxation matters | - | - | - | - | - | - |
Regulatory Proceedings | - | - | - | - | - | - |
Income Statement(in Millions) | March'2021 | March'2020 | March'2019 |
Gross Operating Income | 14,781.58 | 15,442.67 | 15,059.87 |
Cost of Employee & Inventory | 4,663.36 | 5,387.81 | 5,410.80 |
Other Expenses | 12,553.06 | 13,137.91 | 12,680.69 |
Finance Cost | 671.74 | 515.47 | 530.50 |
Depreciation | 1,232.14 | 1,150.40 | 1,016.00 |
Profit Before Tax | 324.64 | 638.87 | 832.42 |
Tax | 36.59 | 275.60 | 319.39 |
Profit After Tax | 288.05 | 363.27 | 513.03 |
DR. Naresh Trehan
• Apollo Hospitals Enterprise Limited • Fortis healthcare limited • Max healthcare enterprise Limited • Narayana Hrudalaya Limited
Proceeds from the Offer for sale, cumulative sale of 4.84 crore equity shares
Net proceed of Rs500cr from the offer for sale will be utilized for the following: • Repayment/prepayment of borrowings, in full or part, of our Subsidiaries, GHPPL and MHPL; and • . General corporate purposes